Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Postpartum Depression Prevention Program in Disaster-Affected Regions
This study has finished and is no longer accepting participants.
In Hatay
A Treatment for Depression Via App-Based FTP (Game4Mood Study)
This study has finished and is no longer accepting participants.
In Boston
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
Read the official source — NCT00246259An Open-Label Randomized Trial Comparing Risperdal Consta With Oral Antipsychotic Care in the Treatment of Early Psychosis
This study has finished and is no longer accepting participants.
Multiple locations, including CalgaryResearchers are comparing Pitolisant (BF2.649) and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
This study was withdrawn before enrollment.
Location not clearly listedResearchers compared HLD200 and placebo, tracking side effects to assess safety in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachA Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In New YorkResearchers studied Centanafadine SR, tracking side effects to assess long-term safety and tolerability in adults with ADHD.
This study has finished and is no longer accepting participants.
In Culver CityA Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
This study ended early.
Multiple locations, including PhoenixA Phase 1 Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Formulations of PRAX-114
This study has finished and is no longer accepting participants.
In AustraliaA Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers compared Emraclidine 10 mg, Emraclidine 30 mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared Emraclidine 15 mg, Emraclidine 30 mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.